* Pulmonx Corp LUNG.OQ reported a quarterly adjusted loss
of 43
cents per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 44
cents per share.
* Revenue rose 23.3% to $17.19 million from a year ago;
analysts
expected $15.86 million.
* Pulmonx Corp's reported EPS for the quarter was a loss
of 43
cents.
* The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Pulmonx Corp shares had risen by 5.3% this quarter and
gained 63.8% so far this year.
* The company reported a quarterly loss of $16.2 million.
* Wall Street's median 12-month price target for Pulmonx
Corp is
$15.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 2 at 09:45 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.44 -0.43 Beat
Mar. 31 2023 -0.44 -0.42 Beat
Dec. 31 2022 -0.42 -0.38 Beat
Sep. 30 2022 -0.40 -0.38 Beat